Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros

Tipo de documento
Intervalo de ano de publicação
1.
J Clin Densitom ; 21(2): 157-162, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28427988

RESUMO

The high prevalence of obesity is a worldwide problem associated with multiple comorbidities, including cardiovascular diseases. Vitamin D deficiency with secondary hyperparathyroidism is common in obese individuals and can be aggravated after bariatric surgery. Moreover, there is no consensus on the optimal supplementation dose of vitamin D in postbariatric surgical patients. We present new data on the variability of 25(OH)D response to supplementation in postmenopausal obese women. It is important to recognize and treat vitamin D deficiency before bariatric surgery to avoid postoperative complications, such as metabolic bone disease with associated high fracture risk. The objective of this article is to discuss the bone metabolism consequences of vitamin D deficiency after bariatric surgery.


Assuntos
Cirurgia Bariátrica/efeitos adversos , Osso e Ossos/metabolismo , Obesidade/complicações , Obesidade/cirurgia , Deficiência de Vitamina D/etiologia , Deficiência de Vitamina D/metabolismo , 25-Hidroxivitamina D 2/sangue , Densidade Óssea , Suplementos Nutricionais , Humanos , Hiperparatireoidismo Secundário/etiologia , Obesidade/metabolismo , Pós-Menopausa/fisiologia , Complicações Pós-Operatórias/prevenção & controle , Fatores de Risco , Vitamina D/uso terapêutico , Deficiência de Vitamina D/tratamento farmacológico
2.
Genet Res (Camb) ; 97: e3, 2015 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-25819804

RESUMO

BACKGROUND: Paraganglioma syndrome type 1 (PGL1) is a rare autosomal dominant syndrome associated with multiple, overwhelmingly benign, pheochromocytomas and paragangliomas, attributed to SDHD gene mutations. OBJECTIVE: Clinically and molecularly characterize a family with uncommon malignant phenotype of paragangliomas attributed to two seemingly pathogenic SDHD germline mutations. MATERIALS & METHODS: The proband presented with large bilateral carotid body tumours and family history of cervical masses in his five siblings. All family members underwent clinical examination, imaging studies (18F-FDG PET/CT) and genotyping of relevant genes. The proband was diagnosed with locally advanced paraganglioma; his hypertensive, otherwise asymptomatic father, had locally advanced pheochromocytoma and his three siblings showed multiple head and neck masses, confirmed to be paragangliomas with local metastasis. All affected patients carried two germline mutations in the SDHD gene; a previously reported nonsense mutation in exon 1 (p.Trp5X) and a novel missense mutation in exon 2 (p.Pro53Leu), highly deleterious by in silico analysis. Allelic loss at the SDHD locus was not shown for any of the analysed tumours. CONCLUSIONS: This is a rare case of malignant PGL1 with seemingly double pathogenic mutations in the SDHD gene, highlighting the possibility that the presence of both mutations is associated with the more aggressive phenotype.


Assuntos
Predisposição Genética para Doença/genética , Mutação , Paraganglioma/genética , Feocromocitoma/genética , Succinato Desidrogenase/genética , Adulto , Sequência de Bases , Códon sem Sentido , Análise Mutacional de DNA , Saúde da Família , Evolução Fatal , Feminino , Genótipo , Mutação em Linhagem Germinativa , Humanos , Masculino , Mutação de Sentido Incorreto , Paraganglioma/patologia , Linhagem , Fenótipo , Feocromocitoma/patologia , Síndrome
3.
BMC Med Genet ; 13: 101, 2012 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-23134754

RESUMO

BACKGROUND: Obesity has become a common human disorder associated with significant morbidity and mortality and adverse effects on quality of life. Sequence variants in two candidate genes, FTO and UCP-1, have been reported to be overrepresented in obese Caucasian population. The association of these genes polymorphisms with the obesity phenotype in a multiethnic group such as the Brazilian population has not been previously reported. METHODS: To assess the putative contribution of both FTO and UCP-1 to body mass index (BMI) and cardiovascular risk we genotyped SNPs rs9939609 (FTO) and rs6536991, rs22705565 and rs12502572 (UCP-1) from 126 morbidly obese subjects (BMI 42.9 ± 5.6 kg/m2, mean ± SE) and 113 normal-weight ethnically matched controls (BMI 22.6 ± 3.5 kg/m2, mean ± SE). Waist circumference, blood pressure, glucose and serum lipids were also measured. Each sample was also genotyped for 40 biallelic short insertion/deletion polymorphism (indels) for ethnic assignment and to estimate the proportion of European, African and Amerindian biogeographical ancestry in the Brazilian population. RESULTS: Cases did not differ from controls in the proportions of genomic ancestry. The FTO SNP rs9939609 and UCP-1 SNP rs6536991 were significantly associated with BMI (p= 0.04 and p<0.0001 respectively). An allele dose dependent tendency was observed for BMI for rs6536991 sample of controls. No other significant associations between any SNP and hypertension, hyperlipidemia and diabetes were noted after correction for BMI and no significant synergistic effect between FTO and UCP-1 SNPs with obesity were noted. There was not an association between rs9939609 (FTO) and rs6536991 (UCP-1) in with maximum weight loss after 1 year in 94 obese patients who underwent bariatric surgery. CONCLUSION: Our data are consistent with FTO rs9939609 and UCP-1 rs6536991 common variants as contributors to obesity in the Brazilian population.


Assuntos
Doenças Cardiovasculares/genética , Diabetes Mellitus/genética , Predisposição Genética para Doença , Canais Iônicos/genética , Proteínas Mitocondriais/genética , Obesidade Mórbida/genética , Polimorfismo de Nucleotídeo Único/genética , Proteínas/genética , Adulto , Dioxigenase FTO Dependente de alfa-Cetoglutarato , Brasil , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Proteína Desacopladora 1
4.
Endocr Pathol ; 31(1): 14-20, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32034658

RESUMO

Thyroid cancer, predominantly of papillary histology (PTC), is a common cancer mostly diagnosed sporadically. Hereditary PTC is encountered in ~ 5% of cases and may present at an earlier age, with greater risks of metastasis and recurrence, compared with sporadic cases. The molecular basis of hereditary PTC is unknown in most cases. In this study, the genetic basis of hereditary PTC in three Brazilian families was investigated. Whole exome sequencing (WES) was carried out for probands in each family, and validated, pathogenic/likely pathogenic sequence variants (P/LPSVs) were genotyped in additional family members to establish their putative pathogenic role. Overall, seven P/LPSVs in seven novel genes were detected: p.D283N*ANXA3, p.Y157S*NTN4, p.G172W*SERPINA1, p.G188S*FKBP10, p.R937C*PLEKHG5, p.L32Q*P2RX5, and p.Q76*SAPCD1. These results indicate that these novel genes are seemingly associated with hereditary PTC, but extension and validation in other PTC families are required.


Assuntos
Predisposição Genética para Doença/genética , Câncer Papilífero da Tireoide/genética , Neoplasias da Glândula Tireoide/genética , Adulto , Brasil , Feminino , Mutação em Linhagem Germinativa , Humanos , Masculino , Linhagem , Sequenciamento do Exoma
5.
Endocrine ; 67(1): 204-208, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31782130

RESUMO

PURPOSE: Parathyroid cancer is a rare tumor associated with poor prognosis particularly when disseminated. While chemotherapy and/or radiotherapy are of no clinical value in disseminated disease, immunotherapy should be considered. SUBJECT AND RESULTS: A patient with CDC73-associated metastatic parathyroid carcinoma was treated with combined anti-hPTH immunotherapy and surgery. CONCLUSIONS: Following five courses of anti-hPTH immunotherapy and subsequent surgery, a 12-year long remission of disseminated parathyroid cancer is reported. This case further supports the ever-expanding spectrum of cancers that may benefit from immunotherapy.


Assuntos
Neoplasias das Paratireoides , Humanos , Imunoterapia , Glândulas Paratireoides , Neoplasias das Paratireoides/terapia
6.
Thyroid ; 17(11): 1055-9, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18047428

RESUMO

CONTEXT: Chromosomal fragile sites are often related to cancer development. The WW domain-containing oxidoreductase gene (WWOX) spans the second most common chromosomal fragile site (FRA16D) and encodes an important proapoptotic protein. OBJECTIVE: To verify our hypothesis that underexpression of WWOX could contribute to malignant transformation of the thyroid cells. METHOD: We compared WWOX expression among follicular adenomas (FAs) and differentiated thyroid carcinomas [follicular thyroid carcinomas (FTCs) and papillary thyroid carcinomas (PTCs)] in 53 thyroid tumors resected from patients submitted to total thyroidectomy. DESIGN: Multiple fields of tumor areas of FAs, FTCs, and PTCs as well as normal thyroid tissue were stained with WWOX antiserum, and classified by the extent of staining (percentage of cells staining) and staining intensity. MAIN OUTCOME: PTCs showed a significantly decreased expression of WWOX when compared to FAs and FTCs. Further, using a unique model of comparison in patients in whom FAs and PTCs were concomitantly present, we detected the same result (i.e., no expression in PTCs). CONCLUSION: We conclude that WWOX underexpression is an important step that might increase the vulnerability to the carcinogenesis process in PTCs.


Assuntos
Oxirredutases/biossíntese , Neoplasias da Glândula Tireoide/etiologia , Proteínas Supressoras de Tumor/biossíntese , Adenocarcinoma Folicular/metabolismo , Carcinoma Papilar/metabolismo , Transformação Celular Neoplásica/metabolismo , Sítios Frágeis do Cromossomo/fisiologia , Humanos , Neoplasias da Glândula Tireoide/fisiopatologia , Oxidorredutase com Domínios WW
7.
J Clin Endocrinol Metab ; 91(1): 262-9, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16249278

RESUMO

CONTEXT: Many mammalian genes that are imprinted regulate cell growth, differentiation, and apoptosis. Because imprinting silences one of the two alleles, resulting in functional haploinsufficiency, we hypothesized that loss of heterozygosity (LOH) at an imprinted locus may result in the deletion of the only functional copy of an imprinted tumor suppressor gene. OBJECTIVE: The goal of this study was to specifically address this hypothesis that in thyroid neoplasias loss of imprinted loci becomes enriched during oncogenesis. DESIGN: In total, thyroid tissue was obtained from 72 patients with thyroid neoplasias comprising 34 follicular thyroid carcinomas (FTCs) and 38 follicular adenomas. We performed PCR-based LOH analysis of DNA from paired normal-tumor samples using 18 markers mapped to imprinted regions (IR) and 13 markers in nonimprinted regions (NIR). RESULTS: Overall LOH frequencies for the IR markers were 26% for the adenomas and 38% for the carcinomas. In the NIR, the overall LOH frequency was 23 and 26% for adenomas and FTCs, respectively. The difference in LOH frequencies between IR and NIR was statistically significant only for the carcinomas (P = 0.001), although there was a similar trend for the atypical adenomas (ATY, P = 0.06). CONCLUSIONS: Our observations suggest that IRs are more prone to genomic instability in FTCs. The fact that the ATY trended toward differential IR/NIR LOH, similar to FTC, may suggest that loss of IR might be instrumental in the adenoma-carcinoma sequence in thyroid carcinogenesis and that ATY could be an important intermediate in this pathway.


Assuntos
Adenoma/genética , Carcinoma Papilar, Variante Folicular/genética , Impressão Genômica , Perda de Heterozigosidade/fisiologia , Neoplasias da Glândula Tireoide/genética , Adenoma/patologia , Carcinoma Papilar, Variante Folicular/patologia , Cromossomos/genética , Regulação Neoplásica da Expressão Gênica , Marcadores Genéticos , Genótipo , Humanos , Análise de Sequência com Séries de Oligonucleotídeos , Neoplasias da Glândula Tireoide/patologia
8.
Arq Bras Endocrinol Metabol ; 49(2): 323-7, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16184265

RESUMO

Pituitary duplication is a rare malformation commonly associated with other major neural/craniofacial anomalies, easily shown by magnetic resonance imaging. The authors describe two girls with duplication of the pituitary gland and thickening of the hypothalamus, facial dysmorphism and precocious pubertal development. The pathogenesis of pituitary duplication and its relationship with precocious pubertal development are discussed.


Assuntos
Hipófise/anormalidades , Puberdade Precoce/etiologia , Criança , Feminino , Humanos , Imageamento por Ressonância Magnética , Hipófise/embriologia
9.
J Clin Endocrinol Metab ; 98(5): 1963-70, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23526463

RESUMO

CONTEXT: In the milder form of primary hyperparathyroidism (PHPT), cancellous bone, represented by areal bone mineral density at the lumbar spine by dual-energy x-ray absorptiometry (DXA), is preserved. This finding is in contrast to high-resolution peripheral quantitative computed tomography (HRpQCT) results of abnormal trabecular microstructure and epidemiological evidence for increased overall fracture risk in PHPT. Because DXA does not directly measure trabecular bone and HRpQCT is not widely available, we used trabecular bone score (TBS), a novel gray-level textural analysis applied to spine DXA images, to estimate indirectly trabecular microarchitecture. OBJECTIVE: The purpose of this study was to assess TBS from spine DXA images in relation to HRpQCT indices and bone stiffness in radius and tibia in PHPT. DESIGN AND SETTING: This was a cross-sectional study conducted in a referral center. PATIENTS: Participants were 22 postmenopausal women with PHPT. MAIN OUTCOME MEASURES: Outcomes measured were areal bone mineral density by DXA, TBS indices derived from DXA images, HRpQCT standard measures, and bone stiffness assessed by finite element analysis at distal radius and tibia. RESULTS: TBS in PHPT was low at 1.24, representing abnormal trabecular microstructure (normal ≥1.35). TBS was correlated with whole bone stiffness and all HRpQCT indices, except for trabecular thickness and trabecular stiffness at the radius. At the tibia, correlations were observed between TBS and volumetric densities, cortical thickness, trabecular bone volume, and whole bone stiffness. TBS correlated with all indices of trabecular microarchitecture, except trabecular thickness, after adjustment for body weight. CONCLUSION: TBS, a measurement technology readily available by DXA, shows promise in the clinical assessment of trabecular microstructure in PHPT.


Assuntos
Doenças Ósseas Metabólicas/etiologia , Reabsorção Óssea/etiologia , Osso e Ossos/patologia , Hiperparatireoidismo Primário/fisiopatologia , Osteoporose Pós-Menopausa/fisiopatologia , Absorciometria de Fóton , Centros Médicos Acadêmicos , Idoso , Densidade Óssea , Doenças Ósseas Metabólicas/epidemiologia , Doenças Ósseas Metabólicas/patologia , Doenças Ósseas Metabólicas/fisiopatologia , Reabsorção Óssea/diagnóstico por imagem , Osso e Ossos/química , Osso e Ossos/diagnóstico por imagem , Fenômenos Químicos , Estudos Transversais , Feminino , Humanos , Hiperparatireoidismo Primário/complicações , Hiperparatireoidismo Primário/patologia , Imageamento Tridimensional , Cidade de Nova Iorque/epidemiologia , Osteoporose Pós-Menopausa/complicações , Osteoporose Pós-Menopausa/epidemiologia , Osteoporose Pós-Menopausa/patologia , Fraturas por Osteoporose/epidemiologia , Fraturas por Osteoporose/etiologia , Prevalência , Risco , Índice de Gravidade de Doença , Tomografia Computadorizada por Raios X
10.
Arq Bras Endocrinol Metabol ; 55(7): 455-9, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22147093

RESUMO

OBJECTIVES: To compare salivary with serum total cortisol in patients with severe sepsis, postoperative patients and healthy controls. MATERIALS AND METHODS: Serum total cortisol was determined by chemiluminescence immunoassay; salivary cortisol was determined by enzyme immunoassay. RESULTS: In patients with severe sepsis, median concentration of salivary cortisol was 14.0 and 2.6 higher than that of postoperative patients and healthy subjects. In postoperative patients, salivary cortisol was 5.4 times higher than in control patients. Serum total cortisol was also higher in patients with severe sepsis than in controls and postoperative patients. This increment, however, was much lower (2.33 and 1.64, respectively). Patients with a salivary cortisol greater than 7.2 µg/dL had a mortality rate of 80%, a statistically significant result when compared with the group with lower cortisol levels (Z = 2.38 and p < 0.05). CONCLUSIONS: Salivary cortisol in critically ill patients may be a better laboratory indicator of cortisol levels than serum total cortisol.


Assuntos
Insuficiência Adrenal/diagnóstico , Hidrocortisona/análise , Saliva/química , Sepse/mortalidade , Insuficiência Adrenal/metabolismo , Biomarcadores/análise , Biomarcadores/sangue , Métodos Epidemiológicos , Feminino , Humanos , Hidrocortisona/sangue , Masculino , Pessoa de Meia-Idade , Valores de Referência , Sepse/metabolismo , Procedimentos Cirúrgicos Operatórios
11.
Thyroid ; 20(6): 657-61, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20470207

RESUMO

BACKGROUND: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy with indolent clinical course and good prognosis. Brain metastases are extremely rare and the average survival time after diagnosis has been reported to be around 12 months. SUMMARY: We here report a 69-year-old patient who was admitted to the emergency room in January 2000 with progressive dizziness, headache, and vomiting. Five years before admission the patient underwent partial thyroidectomy for goiter. On admission, a diagnostic evaluation that included brain magnetic resonance imaging showed multiple brain lesions, and a stereotactic biopsy demonstrated a metastatic carcinoma from primary PTC, with the neoplastic cells staining for thyroglobulin. Total thyroidectomy was then performed, which showed colloid goiter and a PTC metastasis on a cervical lymph node. The patient received 200 mCi of radioactive iodine ((131)I) with suppressive therapy with l-thyroxine thereafter. Subsequently, serial whole-body scanning and magnetic resonance imaging showed multiple brain metastases and the patient received further (131)I treatment, with a total dose of 1.2 Ci in a 10-year span. She also underwent partial surgical resection of brain metastases because complete resection was not feasible. Thereafter, the patient was subjected to whole-brain body radiotherapy with a dose of 44 Gy, followed by two brain gamma knife radiosurgeries (15 Gy each). To date, biochemical tests are within the normal range and the patient remains asymptomatic. CONCLUSIONS: To our knowledge, this is the first report of a 10-year-survival case of brain metastases from PTC, despite this being a bad prognostic factor. A combined approach of surgical excision, (131)I, whole-brain radiotherapy, and gamma knife radiosurgery was successful to treat metastases derived from primary tumor.


Assuntos
Neoplasias Encefálicas/secundário , Carcinoma Papilar/patologia , Neoplasias da Glândula Tireoide/patologia , Neoplasias Encefálicas/radioterapia , Neoplasias Encefálicas/cirurgia , Carcinoma Papilar/radioterapia , Carcinoma Papilar/secundário , Carcinoma Papilar/cirurgia , Humanos , Radiocirurgia , Sobreviventes
12.
Arq Bras Endocrinol Metabol ; 52(8): 1211-20, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19169472

RESUMO

It is still debatable which is the best management to familial forms of hyperparathyroidism. Conservative, minimally invasive or aggressive surgical approaches have been proposed from different groups around the world. Our objective was to study the gene mutation, expression of HRPT2 and the clinical outcome after 32 years of follow-up in one Brazilian kindred with familial isolated hyperparathyroidism (FIHP). Clinical and biochemical data, direct sequencing of the HRPT2 gene, analysis of parafibromin expression using RT-PCR, and immunohistochemistry were done. A nonsense mutation was found in exon 1 (c.96G>A)(p.Trp32X) in all affected members studied. Using RT-PCR, mRNA transcription was altered with complete absence of both transcripts in tumor tissue. Immunohistochemical analysis of tumors showed loss of parafibromin immunoreactivity. In this kindred there was a high prevalence of recurrence (75%), or persistence after less than subtotal parathyroidectomy that led us to consider a more aggressive surgical approach should be discussed among the affected family members, once surgical criteria was met. We concluded that it is necessary to individualize the surgical approach for HRPT2-related hyperparathyroidism until we can gather a better phenotype-genotype correlation in larger series, to best define their treatment.


Assuntos
Adenoma/genética , Hiperparatireoidismo/genética , Neoplasias das Paratireoides/genética , Linhagem , Proteínas Supressoras de Tumor/genética , Adenoma/cirurgia , Adolescente , Adulto , Idoso , Códon sem Sentido , Tomada de Decisões , Procedimentos Cirúrgicos Endócrinos/métodos , Feminino , Expressão Gênica , Humanos , Hiperparatireoidismo/cirurgia , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia , Neoplasias das Paratireoides/cirurgia , RNA Mensageiro/análise , Adulto Jovem
13.
Surgery ; 143(5): 630-40, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18436011

RESUMO

BACKGROUND: Familial forms of hyperparathyroidism are responsible for approximately 10% of the cases of primary hyperparathyroidism, and their management is different from the sporadic forms. Our objective was to study the gene sequence and expression of HRPT2 and clinical outcome regarding recurrence or persistence rates in three Brazilian kindreds with familial hyperparathyroidism after up to 30 years of follow-up. METHODS: Clinical and biochemical data, direct sequencing of germline DNA of the HRPT2 gene, and analysis of parafibromin expression (HRPT2 gene product) using RT-PCR and immunohistochemistry of resected parathyroid neoplasms were performed. RESULTS: Affected members of kindred A were found to carry a novel, germline, nonsense mutation in exon 1 (c.96G>A; W32X) of HRPT2. Six of seven patients who have undergone less than total parathyroidectomy recurred after up to 30 years of follow-up. An unrelated affected patient from kindred B had a germline mutation in exon 7 (c.686delGAGT), and the disease recurred with several pulmonary metastases after 5 years follow-up. The affected member of kindred C also had a previously described mutation in exon 7 (c.679delAG) and the disease recurred after 10 years of follow-up. All parathyroid neoplasms from these families had diffuse loss of expression by immunohistochemistry. CONCLUSIONS: An unacceptable recurrence/persistence rate (80%) associated with increasingly difficult re-operations and risk of parathyroid carcinoma in the setting of germline mutations of HRPT2 gene with familial hyperparathyroidism suggest that a more aggressive operative approach should be undertaken in these patients. Parafibromin immunohistochemistry may serve as a cost-effective screen for HRPT2-related aggressive parathyroid disease.


Assuntos
Hiperparatireoidismo/genética , Proteínas Supressoras de Tumor/genética , Adolescente , Adulto , Idoso , Análise Mutacional de DNA , Feminino , Expressão Gênica , Humanos , Hiperparatireoidismo/cirurgia , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Recidiva , Resultado do Tratamento
14.
Am J Hum Genet ; 79(1): 23-30, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16773562

RESUMO

Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRRS) are autosomal dominant hamartoma syndromes. Germline PTEN mutations have been associated with 85% of CS cases and 65% of BRRS cases and also with other disorders, which are collectively referred to as the "PTEN hamartoma tumor syndrome." The human PTEN gene has been previously found to express two naturally occurring splice variants (SVs). Recently, we identified eight novel naturally occurring PTEN SVs that result in different downstream signaling effects: SV3a, SV3b, SV3c (inclusion of various lengths of intron 3 3' of exon 3), SV5a, SV5b, SV5c, SV5d (inclusion of various lengths of intron 5 3' of exon 5), and SV Delta Ex6 (deletion of exon 6). We therefore sought to characterize the relative expression of 5', middle, and 3' full-length PTEN mRNA (FL-PTEN) and also of these eight PTEN SVs in 85 (65 female and 20 male) patients with CS/BRRS (with or without PTEN mutations) compared with 27 controls, using a SYBR green quantitative polymerase chain reaction method. Significantly reduced FL-PTEN levels were found in the probands, compared with those of controls (P < .01). Apart from FL-PTEN, SV3a is the most consistently relatively underexpressed in patients compared with controls. The patients showed relative underexpression of SV3a and SV3b and overexpression of SV5b (P = .005, P = .02, and P = .04, respectively). Indeed, there appears to be an SV expressional genotype-phenotype correlation in which the SV expressional profiles are distinct among CS, CS-like, and BRRS. The reduced FL-PTEN transcript expression, associated with differential expression of PTEN SVs, regardless of PTEN mutation status, supports the concept that modulation of PTEN inactivation may also occur at the transcription level influencing the specific phenotypes seen in these syndromes.


Assuntos
Perfilação da Expressão Gênica , Síndrome do Hamartoma Múltiplo/genética , PTEN Fosfo-Hidrolase/genética , Splicing de RNA , Sequência de Bases , Primers do DNA , DNA Complementar/biossíntese , Feminino , Humanos , Masculino , Reação em Cadeia da Polimerase , RNA Mensageiro/genética , Síndrome
15.
Arq. bras. endocrinol. metab ; 55(7): 455-459, out. 2011. graf, tab
Artigo em Inglês | LILACS | ID: lil-607491

RESUMO

OBJECTIVES: To compare salivary with serum total cortisol in patients with severe sepsis, postoperative patients and healthy controls. MATERIALS AND METHODS: Serum total cortisol was determined by chemiluminescence immunoassay; salivary cortisol was determined by enzyme immunoassay. RESULTS: In patients with severe sepsis, median concentration of salivary cortisol was 14.0 and 2.6 higher than that of postoperative patients and healthy subjects. In postoperative patients, salivary cortisol was 5.4 times higher than in control patients. Serum total cortisol was also higher in patients with severe sepsis than in controls and postoperative patients. This increment, however, was much lower (2.33 and 1.64, respectively). Patients with a salivary cortisol greater than 7.2 µg/dL had a mortality rate of 80 percent, a statistically significant result when compared with the group with lower cortisol levels (Z = 2.38 and p < 0.05). CONCLUSIONS: Salivary cortisol in critically ill patients may be a better laboratory indicator of cortisol levels than serum total cortisol.


OBJETIVOS: Comparar cortisol salivar com sérico total em pacientes com sepse grave, em pós-operatório e controles normais. MATERIAIS E MÉTODOS: Cortisol sérico total foi determinado por imunoensaio quimioluminescente e cortisol salivar por imunoensaio enzimático. RESULTADOS: Em pacientes com sepse grave, a mediana do cortisol salivar foi 14,0 e 2,6 vezes maior que dos pacientes em pós-operatório e saudáveis. Nos pacientes em pós-operatório, cortisol salivar foi 5,4 vezes maior que o controle. Cortisol sérico total também foi maior em pacientes com sepse grave que nos saudáveis e pós-operatórios, porém, esse incremento foi bem menor (2,33 e 1,64, respectivamente). Pacientes com cortisol salivar superior a 7,2 µg/dL tiveram mortalidade de 80 por cento, com significância estatística, quando comparado com os pacientes com níveis mais baixos (Z = 2,38 e p < 0,05). CONCLUSÕES: Cortisol salivar em pacientes críticos parece ser um melhor marcador da atividade glicocorticoide que o cortisol sérico total.


Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência Adrenal/diagnóstico , Hidrocortisona/análise , Saliva/química , Sepse/mortalidade , Insuficiência Adrenal/metabolismo , Biomarcadores/análise , Biomarcadores/sangue , Métodos Epidemiológicos , Hidrocortisona/sangue , Valores de Referência , Procedimentos Cirúrgicos Operatórios , Sepse/metabolismo
16.
Arq. bras. endocrinol. metab ; 52(8): 1211-1220, Nov. 2008. ilus, tab
Artigo em Inglês | LILACS | ID: lil-503286

RESUMO

It is still debatable which is the best management to familial forms of hyperparathyroidism. Conservative, minimally invasive or aggressive surgical approaches have been proposed from different groups around the world. Our objective was to study the gene mutation, expression of HRPT2 and the clinical outcome after 32 years of follow-up in one Brazilian kindred with familial isolated hyperparathyroidism (FIHP). Clinical and biochemical data, direct sequencing of the HRPT2 gene, analysis of parafibromin expression using RT-PCR, and immunohistochemistry were done. A nonsense mutation was found in exon 1 (c.96G>A)(p.Trp32X) in all affected members studied. Using RT-PCR, mRNA transcription was altered with complete absence of both transcripts in tumor tissue. Immunohistochemical analysis of tumors showed loss of parafibromin immunoreactivity. In this kindred there was a high prevalence of recurrence (75 percent), or persistence after less than subtotal parathyroidectomy that led us to consider a more aggressive surgical approach should be discussed among the affected family members, once surgical criteria was met. We concluded that it is necessary to individualize the surgical approach for HRPT2-related hyperparathyroidism until we can gather a better phenotype-genotype correlation in larger series, to best define their treatment.


A melhor conduta nas formas familiares de hiperparatireoidismo relacionadas a mutações no gene HRPT2 ainda é controvertida. Cirurgias conservadoras, minimamente invasivas ou mais agressivas já foram propostas por diferentes grupos. Objetivamos estudar a seqüência e a expressão do gene HRPT2, além do desfecho clínico, após seguimento de até 32 anos de uma família brasileira com hiperparatireodismo familiar isolado (FIHP). Utilizamos dados clínicos e bioquímicos, seqüenciamento direto do HRPT2 além de análise da expressão da parafibromina através da RT-PCR e imunohistoquímica. Foi identificada mutação nonsense no éxon 1 (c.96G>A)(p.Trp32X) em todos os membros afetados que foram estudados. A análise do mRNA transcrito, através da RT-PCR, demonstrou ausência do transcrito no tecido tumoral. A imunohistoquímica também evidenciou ausência da parafibromina. Nessa família houve alta (75 por cento) prevalência de recorrência ou persistência da doença após paratireoidectomia parcial o que nos levou a considerar fundamental discutir uma abordagem cirúrgica mais agressiva com os outros familiares portadores da mutação caso critérios de indicação cirúrgica sejam atingidos. Dessa maneira, até que estudos mais amplos estabeleçam uma correlação genótipo-fenótipo no hiperparatireoidismo familiar relacionado a mutações no HRPT2, a abordagem cirúrgica deverá ser individualizada.


Assuntos
Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Adenoma/genética , Hiperparatireoidismo/genética , Linhagem , Neoplasias das Paratireoides/genética , Proteínas Supressoras de Tumor/genética , Adenoma/cirurgia , Códon sem Sentido , Tomada de Decisões , Procedimentos Cirúrgicos Endócrinos/métodos , Expressão Gênica , Hiperparatireoidismo/cirurgia , Recidiva Local de Neoplasia , Neoplasias das Paratireoides/cirurgia , RNA Mensageiro/análise , Adulto Jovem
17.
Arq. bras. endocrinol. metab ; 49(2): 323-327, abr. 2005. ilus
Artigo em Inglês | LILACS | ID: lil-409741

RESUMO

Duplicacão pituitária é uma malformacão rara muitas vezes associada a anomalias neurais/craniofaciais, facilmente demonstradas por imagens em ressonância magnética. Os autores descrevem duas criancas do sexo feminino com duplicacão da glândula pituitária e espessamento do hipotálamo, dismorfismo facial e desenvolvimento puberal precoce. Discute-se a etiopatogenia da duplicacão hipofisária e sua relacão com o quadro de puberdade precoce.


Assuntos
Criança , Humanos , Feminino , Hipófise/anormalidades , Puberdade Precoce/complicações , Imageamento por Ressonância Magnética , Hipófise/embriologia
18.
Arq. bras. endocrinol. metab ; 42(3): 181-8, jun. 1998. ilus, tab
Artigo em Português | LILACS | ID: lil-212957

RESUMO

A característica principal dos hormônios é a sua habilidade em interagir com receptores altamente seletivos e ativar vias intracelulares do sinalizaçäo nos órgaos específicos. Após a interaçäo dos hormônios com seus receptores, uma seqüência de reaçöes pode levar ao aumento ou diminuiçäo na atividade de determinadas enzimas que, por sua vez, produzem a resposta fisiológica. Os hormônios säo bioquimicamente classificados em esteróides, peptídeos ou aminas e seus receptores diferem, basicamente, por sua localizaçäo, intra ou extracelular. No presente trabalho, o mecanismo molecular de açäo dos hormônios peptídicos (hidrofílicos) e esteróides (lipofílicos) é discutido.


Assuntos
Humanos , Peptídeos/fisiologia , Sistemas do Segundo Mensageiro/fisiologia , Esteroides/fisiologia , Doenças do Sistema Endócrino/metabolismo , Peptídeos/metabolismo , Receptores Citoplasmáticos e Nucleares/metabolismo , Esteroides/metabolismo
19.
Arq. bras. endocrinol. metab ; 42(2): 102-9, abr. 1998. ilus, tab
Artigo em Português | LILACS | ID: lil-214121

RESUMO

Uma característica fundamental de todas as células eucariotas superiores é o período definido de vida do organismo, propriedade essa que se estende às células somáticas individuais que possuem o crescimento e a divisao altamente regulados. O estudo dos mecanismos de oncogênese tem permitido um conhecimento mais aprofundado desses processos de diferenciaçao e proliferaçao celulares. Alteraçoes genéticas relacionadas aos oncogenes, genes supressores de tumor e genes de reparo de erros de pareamento do DNA, estao ligadas à origem da formaçao dos tumores. O objetivo desta revisao é apresentar, sumariamente, alguns dos principais mecanismos de oncogênese nos tumores endócrinos.


Assuntos
Humanos , Neoplasias das Glândulas Endócrinas/genética , Oncogenes/fisiologia , Neoplasias das Glândulas Endócrinas/fisiopatologia
20.
Arq. bras. endocrinol. metab ; 40(4): 228-31, dez. 1996. ilus
Artigo em Inglês | LILACS | ID: lil-209564

RESUMO

In recent years, the application of DNA technology has led to significant advances in the elucidation of the somatic defects which can occur in several tumors, including oncogene expression, allelic loss and inappropriate gene transcription and translation. Normal cell growth is regulated by many proto-oncogenes encoding proteins and specific mutations can convert these genes in oncogenes, leading to abnormal protein products that are responsible for the growth of malignant cells. Mutations that inhibit GTPase activity of the a subunit of the stimulatory G protein (Gsa) have been demonstrated in approximately a thrid of GH-secreting tumors, in 10 percent of functionless pituitary tumors, and also in corticotropinomas although with far less frequency. These mutations -gsp mutations - stabilize the Gsa in the active state (GTP-bound state), resulting in the permanent activation of adenylyl cyclase, leading to tumorigenesis. In addition, mutations in the a subunit of the inhibitory GTP-binding protein gene (Gi2a), or gip mutations, have been found in a subset of adrenocortical and ovarian tumors. In the present work, using the polymerase chain reaction and denaturing gradient gel electrophoresis, we investigated the existence of gsp and gip mutations in twenty three different endocrine tumors.


Assuntos
Neoplasias do Córtex Suprarrenal/genética , Mutação , Oncogenes/genética , Proteínas de Ligação ao GTP/genética , Eletroforese , Reação em Cadeia da Polimerase , Proteínas de Ligação ao GTP/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA